[SYRS] QoQ Quarter Result on 31-Mar-2018 [#Q1]

Stock
[SYRS] Syros Pharmaceuticals, Inc.
Announcement Date
10-May-2018
Financial Year
2018
Quarter
31-Mar-2018 [#Q1]
Profit Trend
QoQ- 5.48%
YoY- -25.60%
Quarter Report
SYRS's Result
SYRS's Financial Summary
View:
Show?
Quarter Result
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
Revenue 893 412 375 370 0 0 0 -
PBT -18,032 -15,737 -14,047 -14,463 -15,302 -13,825 -13,368 22.01%
Tax 0 0 0 0 -390 0 0 -
NP -18,032 -15,737 -14,047 -14,463 -15,302 -13,825 -13,368 22.01%
Tax Rate - - - - - - - -
Total Cost 18,925 16,149 14,422 14,833 15,302 13,825 13,368 26.00%
Ratio Analysis
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
NP Margin -2,019.26 -3,819.66 -3,745.87 -3,908.92 0.00 0.00 0.00 -
Per Share
31/12/18 30/09/18 30/06/18 31/03/18 31/12/17 30/09/17 30/06/17 CAGR
EPS -5.35 -4.68 -4.27 -4.77 -5.81 -5.26 -5.23 1.51%
EPS Diluted -5.34 -4.68 -4.27 -4.77 -5.81 -5.26 -5.23 1.39%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.